Stenocare A/S

STENO

DK0061078425

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 10:34:46 2024-06-07 EDT			5-day change	1st Jan Change
4.26 ^DKK	-4.91%		-4.05%	+67.72%

05-23	Stenocare A/S Launches Next Generation Medical Cannabis Oil Product in Australia	CI
05-02	Stenocare A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Stenocare A/S Elects Ian Abramowitz as New Board Member

May 16, 2019 at 11:06 am

Stenocare A/S announced that at the AGM held on May 16, 2019, it has approved to elect Ian Abramowitz as new Board member.

Latest news about Stenocare A/S

Stenocare A/S Launches Next Generation Medical Cannabis Oil Product in Australia	05-23	CI
Stenocare A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	05-02	CI
Stenocare A/S Announces That the New STENOCARETHC/CBD Medical Cannabis Oil Product Available for Sale in Denmark	04-18	CI
Stenocare A/S to Deliver New Medical Cannabis Oil Product for Australian Patients	03-12	CI
Stenocare Gets Nod for Sale of Medical Cannabis Oil Product in Denmark	02-26	MT
STENOCARE Receives Approval to Sell a New Medical Cannabis Oil Product in Denmark	02-26	CI
Stenocare A/S Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-22	CI
Stenocare A/S Reports Earnings Results for the Full Year Ended December 31, 2023	02-22	CI
Danish Medical Cannabis Group Stenocare Secures Refinancing Deal	01-12	MT
Stenocare A/S Reaches Refinancing Agreement Covering All Existing Debt of DKK 8.2 Million	01-12	CI
Stenocare Aims to Boost Sales in Australia via Quest Biotech Pharma Team up	12-14	MT
Stenocare A/S Enters into A New Partnership Agreement with Quest Biotech Pharma	12-14	CI
Stenocare A/S Expands Presence with New Medical Cannabis Oil Product	11-23	CI
Stenocare A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
Stenocare to Supply, Sell Medical Cannabis in Germany; Shares Surge	23-10-30	MT
Stenocare Ready to Ship Medical Cannabis to German Patients	23-10-30	CI
Stenocare A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-17	CI
Stenocare A/S Provides Sales Guidance for the Year 2023	23-08-17	CI
Stenocare A/S Provides Update on Their Strong Danish Product Pipeline	23-07-27	CI
Stenocare A/S Reports Earnings Results for the First Quarter Ended March 31, 2023	23-06-20	CI
Stenocare Raises DKK10.7 Million from Oversubscribed Rights Offering; Falls 10%	23-06-12	MT
Denmark’s Stenocare Teams Up with International Partner for New Cannabis Oil Product	23-06-02	MT
Stenocare A/S Reports on Significant Progress in Development of Its New Innovative Medical Cannabis Product	23-06-02	CI
Stenocare A/S Launches IT-Platform for Online Clinics	23-05-30	CI
Denmark's Stenocare Wins Regulatory Nod to Enter German Market	23-05-25	MT

STENOCARE A/S is a Denmark-based company, which is engaged in the production of medical cannabis products to patients. The Companyâs business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The Company distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

Sector

Pharmaceuticals

Calendar

2024-08-20 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
STENOCARE A/S	+67.72%	11.87M
DONG-E-E-JIAO CO.,LTD.	+41.50%	6.2B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-22.89%	4.09B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+9.36%	3.48B
TASLY PHARMACEUTICAL GROUP CO., LTD	-19.39%	2.82B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-11.05%	2.28B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+45.24%	1.94B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+46.81%	1.53B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-7.51%	1.51B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-18.04%	1.47B

Alternative Medicine

Stenocare A/S

Equities

STENO

DK0061078425

Pharmaceuticals

Stenocare A/S Elects Ian Abramowitz as New Board Member

Latest news about Stenocare A/S

Chart Stenocare A/S

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Alternative Medicine